Pediatric pulmonologist Christy Sadreameli discusses her secondary analysis of the Mouse Allergen and Asthma Intervention Trial (MAAIT). The original MAAIT study is a randomized, controlled trial of a home intervention to reduce mouse allergen exposure in mouse-allergic children who have asthma and mouse allergen exposure. In Sadreameli’s secondary study, the researchers determined if three factors in the home were associated with improvement in asthma outcomes: lower baseline home mouse allergen level, lower level of particulate matter, and sensitization and exposure to other indoor allergens.
To read the full study, visit pubmed.ncbi.nlm.nih.gov/34506964.
Video